NCT06917469View on ClinicalTrials.gov

Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO

CompletedOBSERVATIONAL
Enrollment

140

Participants

Timeline

Start Date

June 20, 2018

Primary Completion Date

June 20, 2022

Study Completion Date

June 20, 2022

Conditions
Ovarian Cancer
Trial Locations (1)

Unknown

Centro di Riferimento Oncologico - IRCCS, Aviano

All Listed Sponsors
lead

Centro di Riferimento Oncologico - Aviano

OTHER

NCT06917469 - Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO | Biotech Hunter | Biotech Hunter